The Association of Iodixanol (Visipaque) to Renal Function and Cardiac and Cerebrovascular Events in STEMI Patients Undergoing Primary PCI: A Prospective, Multi-National, Multi-Center, Open-Label, Observational Study
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2019
At a glance
- Drugs Iodixanol (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Sponsors GE Healthcare
- 20 Dec 2018 Status changed from not yet recruiting to recruiting.
- 10 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Oct 2018.
- 20 Sep 2018 New trial record